External Fixators Industry Aspires to Hit US$ 2.7 Billion Milestone by 2028-FMI Report

By 2022, the external fixators industry is expected to grow to a value of about US$ 1.7 billion. The market is expected to reach US$ 2.7 billion by 2028, growing at a rate of 8.1% CAGR. The External Fixators market is critical in orthopaedic care because it provides innovative solutions for fracture stabilisation and bone …

Metagenomics Industry Forecasting a Noteworthy Surge to US$ 394.2 Million by 2033-FMI Report

The metagenomics industry is expected to grow at a compound annual growth rate (CAGR) of 6.9% between 2023 and 2033, according to latest market analysis by FMI. The market forecast for 2023 is $202.9 million USD. By 2033, the estimated value is expected to reach US$ 394.2 million. The market is mainly driven by surging …

Global Home Sleep Screening Devices Industry ascent to US$ 11.4 Billion by 2032 is fueled by the growing desire for convenient solutions | FMI

In 2022, sales of home sleep screening devices industry trends are expected to surpass US$ 3.1 billion. By 2032, the market is expected to hit US$ 11.4 billion thanks to a solid 8.5% CAGR. The importance of sleep health and the rising frequency of sleep disorders have spurred recent years’ strong rise in the Home …

Global Skin Perfusion Pressure Testing Devices Industry is set to experience a 4.5% CAGR through 2030 | FMI

Through 2020 and 2030, the global skin perfusion pressure testing devices industry growth is anticipated to expand at a 4.5% CAGR. The current situation is such that a significant portion of the worldwide population is becoming more and more affected by peripheral vascular disease. Furthermore, the situation is getting worse as the population ages at …

Global Retail Clinics Industry is poised for substantial growth, projecting a CAGR of 9.6% by 2028, according to FMI

The global retail clinics industry size is predicted to exhibit a CAGR of 9.6% throughout the projection period from 2022 to 2028, accounting for a value of US$ 4.64 Billion currently, and is anticipated to reach a market valuation of US$ 8.05 Billion by the end of 2028. The emergence and rising popularity of retail …

Global Gastroesophageal Reflux Disease (GERD) Devices Industry is poised to reach a valuation of US$ 1.5 Billion by 2028 | FMI

The global gastroesophageal reflux disease (GERD) devices industry size exhibited significant growth at the close of 2021, marking a valuation of approximately US$ 1.12 Billion, The global GERD devices market is expected to reach a valuation of US$ 1.17 Billion in 2022. A comprehensive market analysis indicates a promising trajectory ahead, with projections foreseeing a …

Global Urology Imaging Systems Industry is forecasted to attain a valuation of US$ 486.4 Million by 2028 | FMI

In a groundbreaking projection, the global urology imaging systems industry demand is poised to reach unprecedented heights, with anticipated sales set to surpass US$ 486.4 million by 2028, growing at a robust 3.7% CAGR from US$ 391.6 million in 2022. The forecasted surge owes itself to an amalgamation of factors driving the market’s trajectory. The …

Global Tattoo Removal Lasers Industry is expected to surge to US$ 328.5 Million by 2028, buoyed by technological advancements and rising demand | FMI

Sales of tattoo removal lasers industry demand are predicted to increase, rising by 5.7% CAGR from US$ 235.2 million in 2022 to US$ 328.5 million by 2028. The Tattoo Removal Lasers market is anticipated to register enticing revenue growth in the upcoming years. The market value share of tattoo parlours is expected to increase over …

Global Weight Loss and Obesity Management Industry reaching a value of US$ 4.99 Billion by 2028 | FMI Study

The global weight loss and obesity management industry size is expected to have a net worth of US$ 3.68 billion in 2022 and to grow at a CAGR of 5.2% to reach US$ 4.99 billion by value by 2028. One of the most urgent health issues of our time is being addressed by the weight …

Global Generic Oncology Drugs Industry is on the brink of considerable expansion, with an anticipated value of US$ 34.8 Billion by 2028

Sales of generic oncology drugs industry size are anticipated to reach US$ 24.5 billion in 2022 and US$ 34.8 billion by the end of 2028, rising at a 6% CAGR. The main factor causing cancer in people is the rise in tobacco use and smoking. The human body is vulnerable to cancer due to secondary …